Suzette Blanchard

2.2k total citations
40 papers, 1.7k citations indexed

About

Suzette Blanchard is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Suzette Blanchard has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Suzette Blanchard's work include CAR-T cell therapy research (11 papers), Cancer Treatment and Pharmacology (7 papers) and HIV/AIDS drug development and treatment (6 papers). Suzette Blanchard is often cited by papers focused on CAR-T cell therapy research (11 papers), Cancer Treatment and Pharmacology (7 papers) and HIV/AIDS drug development and treatment (6 papers). Suzette Blanchard collaborates with scholars based in United States, Switzerland and Australia. Suzette Blanchard's co-authors include Florin Vaida, Timothy W. Synold, Jana Portnow, Behnam Badie, Stephen J. Forman, Mike Y. Chen, An Liu, James I. Ito, Andrew Dagis and Bernard Tegtmeier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Suzette Blanchard

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzette Blanchard United States 17 335 326 320 241 222 40 1.7k
An Liu United States 27 371 1.1× 200 0.6× 312 1.0× 266 1.1× 59 0.3× 117 2.4k
Robert W. Allan United States 28 265 0.8× 66 0.2× 777 2.4× 307 1.3× 91 0.4× 85 2.3k
Clive Hoggart United Kingdom 18 80 0.2× 144 0.4× 678 2.1× 130 0.5× 118 0.5× 25 2.7k
Wayne Moore United States 18 165 0.5× 117 0.4× 813 2.5× 121 0.5× 125 0.6× 40 2.2k
Joanny Gouvernet France 20 389 1.2× 275 0.8× 259 0.8× 330 1.4× 424 1.9× 45 2.1k
J. Watkins United Kingdom 28 401 1.2× 97 0.3× 990 3.1× 398 1.7× 131 0.6× 122 3.3k
John Ferbas United States 22 206 0.6× 58 0.2× 341 1.1× 340 1.4× 529 2.4× 49 2.0k
Rosane Charlab United States 22 321 1.0× 74 0.2× 634 2.0× 299 1.2× 203 0.9× 46 2.0k
Meena Subramanyam United States 23 1.7k 5.0× 73 0.2× 520 1.6× 274 1.1× 122 0.5× 53 3.2k
J. Berger Germany 21 166 0.5× 33 0.1× 634 2.0× 101 0.4× 56 0.3× 44 2.4k

Countries citing papers authored by Suzette Blanchard

Since Specialization
Citations

This map shows the geographic impact of Suzette Blanchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzette Blanchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzette Blanchard more than expected).

Fields of papers citing papers by Suzette Blanchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzette Blanchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzette Blanchard. The network helps show where Suzette Blanchard may publish in the future.

Co-authorship network of co-authors of Suzette Blanchard

This figure shows the co-authorship network connecting the top 25 collaborators of Suzette Blanchard. A scholar is included among the top collaborators of Suzette Blanchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzette Blanchard. Suzette Blanchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Synold, Timothy W., Behnam Badie, An Liu, et al.. (2024). An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors. Cancer Chemotherapy and Pharmacology. 94(6). 807–813.
2.
Blanchard, Suzette, Stephanie N. Shishido, Tracey Stiller, et al.. (2024). A phase 1b study of PSCA CAR T cells plus or minus radiation for the treatment of patients with PSCA+ metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS5112–TPS5112. 2 indexed citations
3.
Badie, Behnam, Michael E. Barish, Ammar Chaudhry, et al.. (2021). A phase 1 study to evaluate chimeric antigen receptor (CAR) T cells incorporating a chlorotoxin tumor-targeting domain for patients with MMP2+ Recurrent or progressive glioblastoma (NCT04214392).. Journal of Clinical Oncology. 39(15_suppl). TPS2662–TPS2662. 9 indexed citations
4.
Lee, Jin Sun, Susan E. Yost, Suzette Blanchard, et al.. (2019). Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer. Breast Cancer Research. 21(1). 119–119. 27 indexed citations
5.
El-Khoueiry, Anthony B., Robert T. OʼDonnell, Thomas J. Semrad, et al.. (2018). A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 81(5). 957–963. 14 indexed citations
6.
7.
8.
Luu, Thehang, Suzette Blanchard, & John H. Yim. (2014). Phase I/IB trial of eribulin and everolimus in patients with triple-negative metastatic breast cancer.. Journal of Clinical Oncology. 32(15_suppl). TPS2637–TPS2637. 2 indexed citations
9.
Aboody, Karen S., Joseph Najbauer, Marianne Z. Metz, et al.. (2013). Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies. Science Translational Medicine. 5(184). 184ra59–184ra59. 184 indexed citations
10.
Luu, Thehang, Suzette Blanchard, Jan H. Beumer, et al.. (2012). Phase I trial of ixabepilone and vorinostat in metastatic breast cancer.. Journal of Clinical Oncology. 30(15_suppl). 1070–1070. 1 indexed citations
11.
Krymskaya, Ludmila, et al.. (2010). Development and application of a multiplexable flow cytometry‐based assay to quantify cell‐mediated cytolysis. Cytometry Part A. 77A(6). 534–545. 25 indexed citations
12.
Pullarkat, Vinod, Suzette Blanchard, Bernard Tegtmeier, et al.. (2008). Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 42(12). 799–805. 148 indexed citations
13.
Vaida, Florin & Suzette Blanchard. (2005). Conditional Akaike information for mixed-effects models. Biometrika. 92(2). 351–370. 419 indexed citations
14.
Mirochnick, Mark, Alejandro Dorenbaum, Suzette Blanchard, et al.. (2003). Predose Infant Nevirapine Concentration With the Two-Dose Intrapartum Neonatal Nevirapine Regimen: Association With Timing of Maternal Intrapartum Nevirapine Dose. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(2). 153–156. 35 indexed citations
15.
Nachman, Sharon, Soyeon Kim, James C. King, et al.. (2003). Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants With Human Immunodeficiency Virus Type 1 Infection. PEDIATRICS. 112(1). 66–73. 59 indexed citations
16.
Capparelli, Edmund V., Mark Mirochnick, Wayne M. Dankner, et al.. (2003). Pharmacokinetics and tolerance of zidovudine in preterm infants. The Journal of Pediatrics. 142(1). 47–52. 62 indexed citations
17.
Levin, Myron J., Anne A. Gershon, Adriana Weinberg, et al.. (2001). Immunization of HIV-infected children with varicella vaccine. The Journal of Pediatrics. 139(2). 305–310. 111 indexed citations
18.
Hughes, Walter T., Jerry L. Shenep, John H. Rodman, et al.. (2000). Single-Dose Pharmacokinetics and Safety of the Oral Antiviral Compound Adefovir Dipivoxil in Children Infected with Human Immunodeficiency Virus Type 1. Antimicrobial Agents and Chemotherapy. 44(4). 1041–1046. 17 indexed citations
19.
Kline, Mark W., Suzette Blanchard, Courtney V. Fletcher, et al.. (1999). A Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children With Human Immunodeficiency Virus Infection. PEDIATRICS. 103(4). e47–e47. 31 indexed citations
20.
Spector, Stephen A., Suzette Blanchard, Diane W. Wara, et al.. (1997). COMPARATIVE TRIAL OF TWO DOSAGES OF ZALCITABINE IN ZIDOVUDINE-EXPERIENCED CHILDREN WITH ADVANCED HUMAN IMMUNODEFICIENCY VIRUS DISEASE. The Pediatric Infectious Disease Journal. 16(6). 623–626. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by An Liu Breakdown of academic impact, for papers by Robert W. Allan Breakdown of academic impact, for papers by Clive Hoggart Breakdown of academic impact, for papers by Wayne Moore Breakdown of academic impact, for papers by Joanny Gouvernet Breakdown of academic impact, for papers by J. Watkins Breakdown of academic impact, for papers by John Ferbas Breakdown of academic impact, for papers by Rosane Charlab Breakdown of academic impact, for papers by Meena Subramanyam Breakdown of academic impact, for papers by J. Berger
Rankless by CCL
2026